Mohammad Abd Alkhalik Basha

Prof. Dr. Mohammad Abd Alkhalik Basha

Radiology, Zagazig University, Zagazig, Egypt
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2020 in European Radiology
Verified
Journal Article
Closed access
PDF file
Mohammad Abd Alkhalik BashaMohammad Abd Alkhalik Basha
Mohammad Abd Alkhalik Basha
MMMaha Ibrahime Metwally
Maha Ibrahime Metwally
SGShrif A. Gamil
Shrif A. Gamil
HKHamada M. Khater
Hamada M. Khater
SASameh Abdelaziz Aly
Sameh Abdelaziz Aly
HAHesham Youssef Algazzar
Hesham Youssef Algazzar

29 April 2021 in Healthcare
Verified
Journal Article
Open access
PDF file
YAYassir Edrees Almalki
Yassir Edrees Almalki
AQAbdul Qayyum
Abdul Qayyum
MIMuhammad Irfan
Muhammad Irfan
NHNoman Haider
Noman Haider
AGAdam Glowacz
Adam Glowacz
SRSaifur Rahman
Saifur Rahman
The Coronavirus disease 2019 (COVID-19) is an infectious disease spreading rapidly and uncontrollably throughout the world. The critical challenge is the rapid detection of Coronavirus infected people. The available techniques being utilized are body-temperature measurement, along with anterior nasal swab analysis. However, taking nasal swabs and lab testing are complex, intrusive, and require many resources. Furthermore, the lack of test kits to meet the exceeding cases is also a major limitation. The current challenge is to develop some technology to non-intrusively detect the suspected Coronavirus patients through Artificial Intelligence (AI) techniques such as deep learning (DL). Another challenge to conduct the research on this area is the difficulty of obtaining the dataset due to a limited number of patients giving their consent to participate in the research study. Looking at the efficacy of AI in healthcare systems, it is a great challenge for the researchers to develop an AI algorithm that can help health professionals and government officials automatically identify and isolate people with Coronavirus symptoms. Hence, this paper proposes a novel method CoVIRNet (COVID Inception-ResNet model), which utilizes the chest X-rays to diagnose the COVID-19 patients automatically. The proposed algorithm has different inception residual blocks that cater to information by using different depths feature maps at different scales, with the various layers. The features are concatenated at each proposed classification block, using the average-pooling layer, and concatenated features are passed to the fully connected layer. The efficient proposed deep-learning blocks used different regularization techniques to minimize the overfitting due to the small COVID-19 dataset. The multiscale features are extracted at different levels of the proposed deep-learning model and then embedded into various machine-learning models to validate the combination of deep-learning and machine-learning models. The proposed CoVIR-Net model achieved 95.7% accuracy, and the CoVIR-Net feature extractor with random-forest classifier produced 97.29% accuracy, which is the highest, as compared to existing state-of-the-art deep-learning methods. The proposed model would be an automatic solution for the assessment and classification of COVID-19. We predict that the proposed method will demonstrate an outstanding performance as compared to the state-of-the-art techniques being used currently.

19 February 2021 in European Radiology
Verified
Journal Article
Closed access
PDF file
MMMaha Ibrahim Metwally
Maha Ibrahim Metwally
NZNesma Adel Zeed
Nesma Adel Zeed
EHEnas Mahmoud Hamed
Enas Mahmoud Hamed
AEAl Shaimaa Fathi Elshetry
Al Shaimaa Fathi Elshetry
RERabab Mahmoud Elfwakhry
Rabab Mahmoud Elfwakhry
Mohammad Abd Alkhalik BashaMohammad Abd Alkhalik Basha
Mohammad Abd Alkhalik Basha

24 January 2018 in European Radiology
Verified
Journal Article
Closed access
PDF file
Mohammad Abd Alkhalik BashaMohammad Abd Alkhalik Basha
Mohammad Abd Alkhalik Basha
MAMohamad Zakarya AlAzzazy
Mohamad Zakarya AlAzzazy
AAAyman F. Ahmed
Ayman F. Ahmed
HYHala Y. Yousef
Hala Y. Yousef
SSSamar Mohamad Shehata
Samar Mohamad Shehata
EAEman H. Abdelbary
Eman H. Abdelbary

1 January 2021 in International Journal of Hyperthermia
Verified
Journal Article
Open access
MZMohamed M. A. Zaitoun
Mohamed M. A. Zaitoun
SESaeed B. Elsayed
Saeed B. Elsayed
NZNahla A. Zaitoun
Nahla A. Zaitoun
RSRadwa K. Soliman
Radwa K. Soliman
AEAli H. Elmokadem
Ali H. Elmokadem
Mohammad Abd Alkhalik BashaMohammad Abd Alkhalik Basha
Mohammad Abd Alkhalik Basha
To compare safety and efficacy of combined therapy with conventional transarterial chemoembolization (cTACE)+microwave ablation (MWA) versus only TACE or MWA for treatment of hepatocellular carcino...

4 December 2019 in Insights into Imaging
Verified
Journal Article
Open access
PDF file
Mohammad Abd Alkhalik BashaMohammad Abd Alkhalik Basha
Mohammad Abd Alkhalik Basha
SASameh Abdelaziz Aly
Sameh Abdelaziz Aly
AIAhmad Abdel Azim Ismail
Ahmad Abdel Azim Ismail
HBHanan A. Bahaaeldin
Hanan A. Bahaaeldin
SSSamar Mohamad Shehata
Samar Mohamad Shehata
Background: The coronary artery disease reporting and data system (CAD-RADS) is designed for a uniform standardization of coronary computed tomography angiography (CCTA) reporting and further management recommendations of coronary artery disease (CAD). This study aimed to assess clinical validity, applicability, and reproducibility of CAD-RADS in the management of patients with CAD. Methods and results: A single-center prospective study included 287 patients with clinically suspected or operated CAD who underwent CCTA. Four reviewers evaluated the CCTA images independently and assigned a CAD-RADS category to each patient. The invasive coronary angiography (ICA) was used as the reference standard for calculating diagnostic performance of CAD-RADS for categorizing the degree of coronary artery stenosis. The intra-class correlation (ICC) was used to test the inter-reviewer agreement (IRA). Reporting was provided to referring consultants according to the CAD-RADS. Based on ICA results, we have 156 patients with non-significant CAD and 131 patients with significant CAD. On a patient-based analysis, regarding those patients classified as CAD-RADS 4 and CAD-RADS 5 for predicting significant CAD, the CAD-RADS had a sensitivity, specificity, and an accuracy of 100%, 96.8 to 98.7%, and 98.3 to 99.3%, respectively, depending on the reviewer. There was an excellent IRA for CAD-RADS categories (ICC = 0.9862). The best cutoff value for predicting significant CAD was > CAD-RADS 3. Eighty-seven percentage of referring consultants considered CAD-RADS reporting system to be “quite helpful” or “completely helpful” for clinical decision-making in CAD. Conclusion: CAD-RADS is valuable for improving CCTA structural reports and facilitating decision-making with high diagnostic accuracy and high reproducibility.